Piramal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

1,525.30

1,024.14

994.24

846.43

1,054.58

Operating profit

389.64

125.53

86.16

16.59

89.55

Interest

27.66

17.42

28.22

33.80

33.78

Gross profit

415.17

141.22

147.02

9.47

118.65

EPS (Rs)

2.06

0.56

0.58

-0.28

0.35

Other income

53.19

33.11

89.08

26.68

62.88

Stock adjustment

135.74

-120.72

-11.59

-65.05

95.94

Raw material

417.52

444.94

356.76

326.33

308.90

Power and fuel

-

-

-

-

-

Employee expenses

152.88

150.56

151.44

159.05

146.91

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

429.52

423.83

411.47

409.51

413.28

Provisions made

-

-

-

-

-

Depreciation

52.50

51.56

50.83

50.37

53.01

Taxation

89.59

15.32

19.03

-7.54

23.94

Net profit / loss

273.08

74.34

77.16

-33.36

41.70

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

1,322.95

1,322.95

1,322.95

1,193.32

1,193.32

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

25.55

12.26

8.67

1.96

8.49

GPM (%)

26.30

13.36

13.57

1.08

10.62

NPM (%)

17.30

7.03

7.12

-3.82

3.73